A 35-year-old man presents after stated gamma-hydroxybutyric acid (GHB) use.
Before IV access is obtained, he becomes combative and states that he intends to leave. He is then adequately physically restrained, but IV access has still not been achieved and chemical sedation is required.
List four expected clinical manifestations of GHB toxicity.
(Marked out of 4.0)
/ 4
List four key principles when applying physical restraint.
(Marked out of 4.0)
/ 4
State four key steps in your approach to chemical sedation for this patient.
(Marked out of 4.0)
/ 4
Total Score: 0 / 12
Percentage: 0%
Comments are closed for this SAQ.